Risk Factors for Osteoporosis in a Subgroup of Elderly Men in a Veterans Administration Nursing Home
暂无分享,去创建一个
[1] B. Lipworth. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. , 1999, Archives of internal medicine.
[2] R. Petty. Prolactin and antipsychotic medications: mechanism of action , 1999, Schizophrenia Research.
[3] W. Glazer,et al. Neuroleptic-induced hyperprolactinemia , 1999, Schizophrenia Research.
[4] C. Mcevoy,et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[5] D. Bikle. Biochemical markers in the assessment of bone disease. , 1997, The American journal of medicine.
[6] Y. Ouchi,et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. , 1997, The American journal of medicine.
[7] S. Lewis,et al. Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma. , 1997, Thorax.
[8] C. Picado,et al. Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. , 1997, The European respiratory journal.
[9] T. Link,et al. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. , 1997, The Journal of clinical endocrinology and metabolism.
[10] D. Schoenfeld,et al. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. , 1996, The Journal of clinical endocrinology and metabolism.
[11] N. Rojansky,et al. Decreased Bone Mineral Density in Medicated Psychiatric Patients , 1995, Psychosomatic medicine.
[12] J. Baskerville,et al. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. , 1995, The Journal of allergy and clinical immunology.
[13] M. Ip,et al. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. , 1994, Chest.
[14] H. Yokoyama,et al. [Bone mineral loss in patients with chronic obstructive pulmonary disease]. , 1993, Nihon Kyobu Shikkan Gakkai zasshi.
[15] H. Perry,et al. Effects of Testosterone Replacement Therapy in Old Hypogonadal Males: A Preliminary Study , 1993, Journal of the American Geriatrics Society.
[16] J. Devogelaer,et al. Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study. , 1992, Maturitas.
[17] R. Poses,et al. Does Hypogonadism Contribute to the Occurrence of a Minimal Trauma Hip Fracture in Elderly Men? , 1991, Journal of the American Geriatrics Society.
[18] I. Reid,et al. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. , 1990, Archives of internal medicine.
[19] K. Ataya,et al. Osteoporosis associated with neuroleptic treatment. A case report. , 1990, The Journal of reproductive medicine.
[20] C. Cooper,et al. Physical activity and calcium intake in fracture of the proximal femur in Hong Kong. , 1988, BMJ.
[21] K. Moghissi,et al. Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia. , 1988, Fertility and sterility.
[22] J. Riancho,et al. Vertebral compression fractures and mineral metabolism in chronic obstructive lung disease. , 1987, Thorax.
[23] Platt Jj,et al. Criteria for the diagnosis of PTSD. , 1987 .
[24] L. Melton,et al. Risk factors for spinal osteoporosis in men. , 1983, The American journal of medicine.
[25] G. Sergi,et al. Bone Mineral Density and Body Composition in Underweight and Normal Elderly Subjects , 2000, Osteoporosis International.
[26] G. V. Burke,et al. Neuroleptics, prolactin, and osteoporosis. , 1987, American Journal of Psychiatry.